AI therapeutics firm Deep Genomics inks Series B
Toronto-based Deep Genomics, an artificial intelligence therapeutics company, has raised US$40 million in Series B funding.
Toronto-based Deep Genomics, an artificial intelligence therapeutics company, has raised US$40 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination